Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071)

PHASE3CompletedINTERVENTIONAL

Enrollment

393

Participants

Timeline

Start Date

May 27, 2005

Primary Completion Date

February 24, 2006

Study Completion Date

February 26, 2006

Conditions

Migraine

Interventions

DRUG

MK0462, rizatriptan benzoate / Duration of Treatment -1 day

DRUG

Comparator: placebo / Duration of Treatment - 1 day

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00111709 - Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071) | Biotech Hunter | Biotech Hunter